Search for Jobs

11 Results
Laboratory of Tumor Immunology and Biology
Bethesda, MD, United States
30+ days ago
Mayo Clinic
Scottsdale, AZ, United States
12 days ago
Cincinnati Children's Hospital & Research Foundation
Cincinnati, OH, United States
28 days ago
University of Virginia
Charlottesville, VA, United States
29 days ago
Moffitt Cancer Center
Tampa, FL, United States
30+ days ago
Revolution Medicines
Redwood City, CA, United States
30+ days ago
Fred Hutchinson Cancer Research Center
Seattle, WA, United States
30+ days ago
Mayo Clinic
Scottsdale, AZ, United States
30+ days ago
U.S. FDA - Center for Biologics Evaluation and Research
Silver Spring, MD, United States
30+ days ago
University of Washington
WA, United States
30+ days ago
Indiana University
IN, United States
30+ days ago
1 - 11 Results of 11
Preferred Member Company
Laboratory of Tumor Immunology and Biology
Bethesda, Maryland, United States
30+ days ago


The Center for Immuno-Oncology (CIO) Translational Research area at the National Cancer Institute functions as a multidisciplinary and interdisciplinary translational research programmatic effort with the goal of developing novel immunotherapies and immunotherapeutic strategies for cancer. Focus is placed on the development of novel immunotherapeutics, not only as monotherapies, but more importantly, in combination with other immune-mediating modalities, and other conventional or experimental therapies, as part of an immuno-oncology programmatic effort. Within this effort are several research groups which interact closely with the clinical groups of the CIO, and with collaborators within the NCI intramural and extramural programs, and with investigators in the private sector. As Co-Director of the CIO, Dr. Jeffrey Schlom directs the Translational Research area of investigation with Dr. James Hodge as Deputy Director for Translational Research.

The program takes advantage of the uniqueness of the NCI intramural program in that it spans high-risk basic discovery research in immunology genomics and tumor biology, through preclinical translational research, to paradigm-shifting clinical trials. Focus is placed on the design and development of novel 'off-the-shelf' recombinant (rec.) immunotherapeutics that can be used in clinical studies at numerous institutions. A major strength of the program is the rapid translation of preclinical studies to hypothesis-generating clinical trials.

We are looking for post-doctoral fellows interested in learning immunology and immunotherapy. This full-time training position is available immediately. The appointment duration is up to 5 years. Stipends are commensurate with education and experience.

 Please refer to the the Center for Immuno-Oncology's website< >

and Dr. Schlom’s profile page > to learn more about the CIO and its research.

DHHS, NIH and NCI are equal opportunity employers. The NCI and CCR are deeply committed to diversity of thought, equity and inclusion and encourage applications from qualified women, underrepresented minorities and individuals with disabilities.


Ph.D., M.D. or equivalent in immunology, molecular/cell biology or experimental pathology.

Job Information

  • Job ID: 62546131
  • Location:
    Bethesda, Maryland, United States
  • Position Title: Tumor Immunology, Immunotherapy - Post-Doctoral Fellow
  • Company Name For Job: Laboratory of Tumor Immunology and Biology
  • Job Function: Scientific Research: Translational
  • Work Setting: Government/Regulatory
  • Job Type: Full-Time
  • Min Education: Ph.D.

Please refer to the company's website or job descriptions to learn more about them.

View Full Profile

Jobs You May Like
Job Function
Work Setting